ChiCTR2300078849 版本V1.0 版本创建时间2023/12/20 09:01:16 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300078849 

最近更新日期:

Date of Last Refreshed on:

2023-12-20 09:00:54 

注册时间:

Date of Registration:

2023-12-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

影响开颅术后患者肺部CT成像的危险因素与术后肺部并发症的相关性研究

Public title:

To investigate the correlation between risk factors affecting lung CT imaging and the occurrence of postoperative pulmonary complications in patients after craniotomy.

注册题目简写:

English Acronym:

研究课题的正式科学名称:

开颅术后患者肺部CT成像的危险因素与术后肺部并发症的相关性研究

Scientific title:

The correlation between risk factors for post-craniotomy patients’ lung CT imaging and postoperative pulmonary complications.

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

余娅 

研究负责人:

高进 

Applicant:

Ya Yu 

Study leader:

Gao Jin 

申请注册联系人电话:

Applicant telephone:

+86 185 8002 0379

研究负责人电话:

Study leader's telephone:

+86 132 0618 9656

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

328919495@qq.com

研究负责人电子邮件:

Study leader's E-mail:

13777754@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区友谊路1号重庆医科大学附属第一医院

研究负责人通讯地址:

重庆市渝中区友谊路1号重庆医科大学附属第一医院

Applicant address:

No.1 Youyi Road, Yuzhong District, Chongqing City, Chongqing Medical University Affiliated First Hospital,China

Study leader's address:

City, Chongqing Medical University Affiliated First Hospital,China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属第一医院

Applicant's institution:

The First Affiliated Hospital Chongqing Medical University .

研究负责人所在单位:

重庆医科大学附属第一医院

Affiliation of the Leader:

The First Affiliated Hospital Chongqing Medical University .

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023年科研伦理(2022-K477)

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of The First Affiliated Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-10-11 00:00:00

伦理委员会联系人:

重庆医科大学附属第一医院伦理委员会

Contact Name of the ethic committee:

Ethics Committee of The First Affiliated Hospital of Chongqing Medical University

伦理委员会联系地址:

重庆市渝中区友谊路1号重庆医科大学附属第一医院伦理委员会

Contact Address of the ethic committee:

Ethics Committee, the First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23 6881 1360

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属第一医院

Primary sponsor:

The First Affiliated Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区友谊路1号

Primary sponsor's address:

1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第一医院

具体地址:

渝中区友谊路1号

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Address:

1 Youyi Road, Yuanjiagang, Yuzhong District

经费或物资来源:

Source(s) of funding:

none

Target disease:

Patients undergoing craniotomy

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

探讨影响开颅术后患者肺部CT异常成像的因素,并评价术后肺部CT异常成像对开颅术后患者肺部并发症的影响。  

Objectives of Study:

Investigating factors influencing abnormal CT imaging of the lungs in patients after craniotomy, and evaluating the impact of postoperative lung CT imaging on complications of the lungs in patients after craniotomy.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)本院首次接受择期全麻下开颅手术患者,年龄≥18岁,性别不限,ASA分级Ⅰ~Ⅲ级; (2)患者病历资料完整。

Inclusion criteria

(1) First-time scheduled craniotomy patients under general anesthesia, aged ≥18, any gender, ASA classification grade I to III. (2) Patients with complete medical records.

排除标准:

(1)既往接受开颅手术患者; (2)术前已经存在肺部感染或其他肺部疾病患者(第1秒用力呼气容积<80%预期值或第1秒用力呼气容积/用力肺活量比值<70%预期值或一氧化碳弥散量<80%预其值); (3)术前胸部CT提示:肺部影像学表现为单侧或双侧条带状、斑片状、高密度的阴影; (4)围术期病历资料不完善患者。

Exclusion criteria:

(1) Patients who have previously undergone craniotomy. (2) Patients with pre-existing lung infections or other pulmonary diseases (forced expiratory volume in 1 second <80% of predicted value, or forced expiratory volume in 1 second/forced vital capacity ratio <70% of predicted value, or carbon monoxide diffusion capacity <80% of predicted value). (3) Preoperative chest CT indicating unilateral or bilateral linear, patchy, or high-density shadowing in lung imaging. (4) Patients with incomplete medical records during the perioperative period.

研究实施时间:

Study execute time:

From 2023-12-20 00:00:00 To 2024-01-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-12-20 00:00:00 To 2024-01-15 00:00:00  

干预措施:

Interventions:

组别:

肺CT正常组

样本量:

70

Group:

Normal group of pulmonary CT

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

组别:

肺CT异常组

样本量:

70

Group:

Abnormal group of pulmonary CT

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

重庆医科大学附属第一医院 

单位级别:

三级甲等  

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后肺部并发症

指标类型:

主要指标

Outcome:

Postoperative pulmonary complications.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院时间

指标类型:

主要指标

Outcome:

hospital stay

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后抗生素使用天数

指标类型:

主要指标

Outcome:

Postoperative antibiotic usage days

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Do not share IPD

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Excel表格和SPSS软件

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Excel and SPSS

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-12-20 09:00:54